Scientists test new drug duo to fight Virus-Driven cancers
NCT ID NCT04902443
Summary
This early-stage study aims to find a safe dose of two drugs, pomalidomide and nivolumab, for adults whose cancers are caused by viruses. It is for people with cancers like Kaposi sarcoma, certain lymphomas, and HPV-linked cancers that have not responded to standard treatments. The goal is to see if this combination can better control these difficult-to-treat cancers by boosting the immune system's attack.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.